Tag: GSK

GSK to close OTC plant in Pennsylvania

GlaxoSmithKline, one of the world’s largest pharmaceutical companies, confirmed that it will close a manufacturing facility in Carlisle next year. Production in Carlisle will end by mid-2021, the B...

GSK Will Provide its Pandemic Vaccine Adjuvant Technology

British drugmaker GlaxoSmithKline (GSK) has collaborated with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the novel Coronavirus (2019-nCoV). Under the deal, ...

GSK Licenses Tuberculosis Vaccine Candidate to the Gates MRI

gsk
GSK announced that it has licensed its M72/AS01E tuberculosis disease (TB) vaccine candidate to the Gates MRI, paving the way for continued development and potential use of the vaccine candidate in lo...

GSK Has Temporarily Stopped Manufacturing some of Its over the Counter Excedrin Products

GSK spokesperson explained that through routine quality control and assurance measures, it discovered inconsistencies in the transferring and weighing of ingredients for two products. The medications ...

GSK Completed Sale of Rabipur and Encepur to Bavarian Nordic

gsk
GlaxoSmithKline (GSK) has completed the sale of its travel vaccines Rabipur for rabies, and Encepur for tick-borne encephalitis, to Bavarian Nordic. Under the terms of the transaction agreement...

GSK Announced Full Results from Belantamab Mafodotin DREAMM-2 Study

gsk
GlaxoSmithKline announced full results from the DREAMM-2 study, with data showing that belantamab mafodotin was associated with an overall response rate (ORR) of 31% in patients with relapsed/refracto...

GSK Agreed to Deliver to Russia Fortum for Treatment of Cystic Fibrosis for Free

gsk
The Ministry of Health of the Russian Federation has agreed with the pharmaceutical company GlaxoSmithKline on the supply of the drug Fortum (ceftazidime) for patients with cystic fibrosis. Accordi...

GSK Announced Positive Results of Nucala Study in the Treatment of HES Patients

gsk
GlaxoSmithKline plc announced positive results from the pivotal study of Nucala (mepolizumab) in the treatment of patients living with Hypereosinophilic Syndrome (HES), making it the first treatment t...

GSK Benlysta Approved in EU

gsk
GlaxoSmithKline plc announced that the European Commission has adopted a decision to extend to children five years and older, the existing adult indication for intravenous Benlysta (belimumab) as add-...

GSK’s M72/AS01E Candidate Vaccine Reduced Incidence of Pulmonary Tuberculosis Disease

tb
GSK and IAVI reported that GSK’s M72/AS01E candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease (TB) in HIV-negative adults with latent TB infection. These result...

GSK Secured FDA Approval for Zejula

gsk
GlaxoSmithKline (GSK) has secured expanded approval from the US Food and Drug Administration (FDA) for its Zejula (niraparib) for the late-line treatment for women with recurrent ovarian cancer. ...

GlaxoSmithKline Agreed to Sell Travel Vaccines Rabipur

gsk
GlaxoSmithKline plc announced the divestment of travel vaccines Rabipur (tradename Rabavert in the United States) for the prevention of rabies, and Encepur for the prevention of tick-borne encephaliti...

GSK Proposed to Reduce Tivikai Price

gsk
The British drug manufacturer GSK expressed the Russian Ministry of Health its proposal to reduce the price of its drug for the treatment of HIV dolutegravir (Tivikai) by 27%, Kommersant reports citin...

MHRA Issued Alert over GSK Recall of Zantac

The MHRA has issued an alert to heathcare professionals, as GlaxoSmithKline is recalling all unexpired stock of four types of Zantac, the medicine used to treat conditions such as heartburn and stomac...

GSK Announced Five-Year Collaboration with Lyell Immunopharma

gsk
GlaxoSmithKline plc announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to improve cell therapies for cancer patients. The c...

GSK Announced Recall of Zantak® in Russia

The Federal Service for Supervision of Healthcare announced the decision of GlaxoSmithKline Trading JSC (formerly GlaxoSmithKline Trading CJSC), which holds the registration certificate for the drug Z...